OptimizeRx Corp (NASDAQ:OPRX)
| Market Cap | $126.68M-56.2% |
| Revenue (ttm) | $94.20M-14.0% |
| Net Income | $5.02M+14655.9% |
| EPS | $0.25+7558.8% |
| Shares Out | 18.91M |
| PE Ratio | 25.42 |
| Forward PE | 6.36 |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 186,715 |
| Open | $6.96 |
| Previous Close | $7.01 |
| Day's Range | $6.57 - $7.06 |
| 52-Week Range | $4.54 - $15.59 |
| Beta | 1.15 |
| Analysts | Buy |
| Price Target | $11.33(+69.10%) |
| Earnings Date | Mar 4, 2027 |
About OPRX
OptimizeRx Corp. is digital health company, engaged in the provision of digital health messaging via electronic health records, which serve as a direct channel for pharmaceutical companies to communicate with healthcare providers. It offers electronic health record (EHR) workflow solutions which include financial messaging, patient education, and brand messaging and brand support. The company was founded by David A. Harrell in 2006 and is headquartered in Waltham, MA.
Analyst consensus
3 firms rating OPRX in the last 3 months, one vote each. Issuer-paid research is not counted.
Next catalysts
- Mar 4, 2027Earnings report
$OPRX stock is featured in our Insider Trades datasets.
→ All Stock ListsRecently reported changes in OPRX holdings by institutional investors
Latest 0 13F filings · Source: SEC EDGAR
View all institutional owners →Insider Trading
Quarterly net insider trading by OPRX's directors and management
Source: SEC EDGAR (Form 4)
Corporate Lobbying
OPRX Estimated quarterly lobbying spending
Source: U.S. Senate LDA
U.S. Patents
New OPRX patent grants
Source: USPTO Open Data Portal
Government Contracts
Estimated quarterly amount awarded to OPRX from public contracts
Source: USAspending.gov
Top ETF Holders
ETFs with the largest estimated holdings in OPRX
| VTIVanguard Morningstar Total Stock Market ETF | $3.63M |
| DFSVU.S. Small Cap Value Portfolio ETF Class Shares | $2.17M |
| VXFVanguard Extended Market ETF | $1.75M |
| IWCiShares Micro-Cap ETF | $349.47K |
| ITOTiShares Core S&P Total U.S. Stock Market ETF | $327.60K |
| DFMCU.S. Micro Cap Portfolio ETF | $158.66K |
Estimated from each fund’s disclosed top holdings × AUM
Bull Case vs Bear Case
AI-generated from OPRX’s recent data — informational, not investment advice
What’s Behind the Score
News check: Q3 earnings beat estimates with margin expansion, but revenue fell and stock dropped after hours; analyst downgrade partially offsets positive earnings surprise.
